The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 08, 2026 for Gabs Investments Pvt Ltd
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Promoter Gabs Investments Pvt Ltd has created a pledge on 27,70,000 shares of Ajanta Pharma Ltd, which is about 2.22% of the company's total share capital. The pledge was created on June 2, 2026, in favor of CTL Trusteeship Limited, and the stated reason is to raise a new loan. Gabs Investments holds 1,80,78,147 shares (14.47% of share capital) in the company, and before this event it had no shares pledged, so this is a fresh pledge. The disclosure was filed on June 3, 2026, under SEBI's SAST Regulations by Aayush Agrawal, Director of Gabs Investments. The total promoter group continues to hold a substantial stake, with multiple family members and trusts appearing in the promoter table.
This is a small pledge creation covering only 2.22% of total share capital, so the immediate impact on the stock is limited. However, retail investors should watch for any further pledges or any sign of margin calls, as large or repeated pledging can sometimes signal financial stress at the promoter level.